Clinical Trial Update: Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer [NA]

View source ↗

Summary

A clinical trial evaluating postoperative hypofractionated intensity-modulated radiotherapy for endometrial cancer is currently recruiting, sponsored by Samsung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Endometrial Cancer | NA | Status: RECRUITING